NOTE FROM TED: Please do not look to this talk for mental health advice. This talk represents the speaker's personal research approach to psychedelics. Experiments discussed in this talk should not be performed outside of accredited research settings. TEDx events are independently organized by volunteers. The guidelines we give TEDx organizers are described in more detail here: storage.ted.com/tedx/manuals/t...
Thousands of people around the world have begun to the practice of microdosing psychedelics, like LSD and psilocybin, for its proposed health benefits. Clinical Scientist, Joseph Rootman, collaborated with an international team of researchers to deploy the largest study of psychedelic microdosing to date. He will guide listeners through the findings of this study and introduce them to the who, what, and why of this new and interesting practice. Joseph Rootman is a PhD candidate in the clinical Psychology program at the University of British Columbia. He works under the supervision of Dr. Zach Walsh as part of the Therapeutic, Recreational, and Problematic Substance use lab with a research focus in the therapeutic potential of cannabis and psychedelics such as psilocybin, LSD and Ketamine. Joseph is lead author on two recent publications in Nature: Scientific Reports which highlight the potential therapeutic benefits of psychedelic microdosing on mood,
mental health, and cognition. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at www.ted.com/tedx